Your browser doesn't support javascript.
loading
The Mutant p53-Targeting Compound APR-246 Induces ROS-Modulating Genes in Breast Cancer Cells.
Synnott, Naoise C; Madden, Stephen F; Bykov, Vladimir J N; Crown, John; Wiman, Klas G; Duffy, Michael J.
Afiliação
  • Synnott NC; UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
  • Madden SF; Data Science Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Bykov VJN; Karolinska Institutet, Dept. of Oncology-Pathology, Cancer Center Karolinska (CCK), Stockholm, Sweden.
  • Crown J; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.
  • Wiman KG; Karolinska Institutet, Dept. of Oncology-Pathology, Cancer Center Karolinska (CCK), Stockholm, Sweden.
  • Duffy MJ; UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland; UCD Clinical Research Centre, St. Vincent's University Hospital, Dublin, Ireland. Electronic address: MICHAEL.J.DUFFY@UCD.IE.
Transl Oncol ; 11(6): 1343-1349, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30196236

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article